News

Dr. Reddy’s Laboratories Ltd. announced that USFDA has approved to launch Doxorubicin Hydrochloride Liposome Injection for intravenous use, in the US market. The approval is an outcome…
Read More...

Dr. Donna Morgan Murray has been appointed as Nativis Chief Regulatory Officer with immediate effective. Murray is author of more than 60 publications in peer-referenced…
Read More...

Saneca Pharma announced that after an inspection Russian Federal State Institution ‘State Institute of Drugs and Good Practices’ has granted them multi-dosage cGMP certificate. cGMP…
Read More...

MilliporeSigma announced that SystImmune has selected its CHOZN Expression System for commercial development of a bi-specific antibody therapeutic. The CHOZN expression system is…
Read More...

AVEO Oncology has appointed Matthew Dallas as CFO (chief financial officer) effective from June 1, 2017. Mr. Dallas will be responsible for the Company’s financial strategy and…
Read More...

Cambrex Corporation will invest $2.4M is to expand pilot plant capacity by around 30% at its High Point, NC facility with the installation of a fourth reactor suite. The new 400 sq.…
Read More...

Halo Pharma announces the formation of its Pediatric Center of Excellence in support of the development and manufacture of dosage forms tailored for pediatric indications. Halo Pharma…
Read More...

Bristol-Myers Squibb (BMS) and Calithera Biosciences expanded their collaboration to evaluate BMS’s Opdivo in combination with Calithera’s CB-839 in patients with non-small cell lung…
Read More...

NOXXON Pharma signed an agreement with the National Center for Tumor Diseases (NCT) in Heidelberg. Under the agreement NCT will conduct a trial evaluating NOXXON’s lead product…
Read More...

AMAG Pharmaceuticals announced that Helen Milton has been appointed as AMAG's Regulatory Affairs vice president. She will be responsible for regulatory activities along with company’s…
Read More...

Synlogic announced that it has entered into a definitive merger agreement with a wholly owned subsidiary of Mirna in an all-stock transaction and will continue under the Synlogic name.…
Read More...

Catalent Pharma Solutions announced that it has collaborated with Therachon AG to support preclinical and clinical development of TA-46. TA-46 is a novel protein addressing…
Read More...

Thermo Fisher Scientific and Patheon together announced that their boards of directors have approved Thermo Fisher's acquisition of Patheon at a price of $7.2 billion. Thermo Fisher…
Read More...

Upon the approval from the FDA to sell vadadustat to Fresenius Medical Care dialysis clinics in the US, Akebia Therapeutics and Vifor Pharma Group entered into an exclusive license…
Read More...

Patheon announced that with an investment of $26 million it has updated sterile Pharmaceutical Development Services (PDS) suites at its Greenville, NC manufacturing site. The PDS Suites…
Read More...

DelMar Pharmaceuticals  announced that it has signed collaboration agreement with PRA Health Sciences for company's Phase 3 trial of VAL-083 in recurrent glioblastoma multiforme (GBM).…
Read More...

Jose Carmona (Pepe) has been appointed as CFO of Radius health. He will succeed to Nick Harvey, who will continue as an advisor to the Company in the areas of Finance, Business…
Read More...

Biogen has acquired Remedy Pharmaceuticals’ Phase 3 candidate CIRARA (intravenous glyburide). The target indication for CIRARA is large hemispheric infarction (LHI), a severe form of…
Read More...

Siemens Healthineers announced its strategic partnership with Imricor medical system to develop an integrated solution that combines the clinical benefits of real-time MRI scans with…
Read More...

Pfizer announced that its 13-valent Pneumococcal Conjugate (PCV13) Vaccine has been selected for immunization program of India’s babies in select states. Results of the…
Read More...